Raj Makkar, MD, Cedars-Sinai, explains the late-breaking data from the Align-AR trial on the first 500 patients treated for aortic regurgitation using the Jena Valve TAVR device.
The late-breaking five-year results of the Evolut Low-Risk Trial presented at the American College of Cardiology (ACC) 2025 meeting in late March, showed positive results for the Evolut transcatheter aortic valve replacement (TAVR) system vs. surgical aortic valve replacement (SAVR).
The effect shows up on functional MRI as increased brain activity in regions involved in pain, emotion and attention—not only during the procedure but also afterward, when patients remember the experience and score its discomfort level.
Six radiologists interpreting around 500 chest radiographs with an assist from AI bested unaided radiologists in measures of efficiency and/or accuracy in a new comparative performance study.
New research, published in JAMA Cardiology, challenges the common belief that AFib is more likely to develop among men than women. The key problem, it seems, is that prior research teams did not understand the significance of certain risk factors.
Two branch chiefs with the cancer imaging program at NIH’s National Cancer Institute have produced a written commemoration to mark the golden anniversary of 1971’s National Cancer Act.
Over the five-year period ending last December 31, only a third of 218 scientific articles on AI in four popular radiology journals shared the researchers’ code.
